Law firms Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business · 1 February 2016 · 1 min read Corporate and M&A Cravath, Swaine & Moore Kirkland & Ellis Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryRevolving Doors: Kirkland hires top IP barrister as Gibson Dunn builds City real estate practiceLaw firmsNews Editor2 Jun 2026Kirkland launches Tokyo office with three-lawyer hire from US rivalsLaw firmsTom Cox1 Jun 2026Kirkland set to spend $500m on its own global AI platformLaw firmsTom Cox28 May 2026Five firms ordered in for Uber’s €10bn Delivery Hero bidLaw firmsKate Peacock2 Jun 2026Freshfields appoints M&A star as new US managing partnerLaw firmsWill Lewallen1 Jun 2026‘It’s harder than it looks’ – inside the $1.65bn elite Indian cricket sale with the Macfarlanes partners behind the dealLaw firmsTom Cox29 May 2026Revolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesLaw firmsAnna Huntley9 Jan 2025‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetryLaw firmsAnna Huntley7 Jan 2025Five partners vie to succeed Hoyland as Simmons managing partnerLaw firmsTom Cox7 Jan 2025